Clinical Trials at West Virginia University
As of August 2026, 57 paid clinical trials are recruiting at West Virginia University, located at 101 STADIUM DR, MORGANTOWN, WV 26507-0897, MORGANTOWN, WV 26506-7911, phone (304) 293-7401 in Morgantown, West Virginia. Active studies at this site cover conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8 and Coronary Artery Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
57 clinical trials at West Virginia University
·Clear filters·A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
MMA Embolization for Refractory Chronic Migraine
A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR®) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Registry of Arthrex Hand and Wrist Products
EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry
Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Rural Adult and Youth Sun Protection Study
Dental-Child Interaction Training
Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
Clarifying the Optimal Application of SLT Therapy Trial
Common conditions studied in Morgantown
- Breast Cancer (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Coronary Artery Disease (4 active studies)
- Ovarian Cancer (4 active studies)
- Atopic Dermatitis (3 active studies)
- Cancer (3 active studies)
Leading research sponsors in Morgantown
- West Virginia University
- National Cancer Institute (NCI)
- AstraZeneca
- AbbVie
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Morgantown?
There are approximately 225 recruiting clinical trials in Morgantown, West Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Morgantown pay participants?
Most recruiting trials in Morgantown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Morgantown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Morgantown?
The most common conditions under active study in Morgantown include Breast Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Coronary Artery Disease (4), Ovarian Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Morgantown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Morgantown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Morgantown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Morgantown?
Recruiting research sites in Morgantown include West Virginia University, West Virginia University Healthcare, West Virginia University Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Morgantown right now?
The largest active categories in Morgantown are Cancer & tumors (83), Cardiovascular (17), Neurology & pain (16). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of West Virginia University?
West Virginia University is located at 101 STADIUM DR, MORGANTOWN, WV 26507-0897, MORGANTOWN, WV 26506-7911. Use the Google Maps link in the intro above to get directions.
How do I contact West Virginia University?
You can reach West Virginia University by phone at (304) 293-7401. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.